News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
173,921 Results
Type
Article (7137)
Company Profile (38)
Press Release (166746)
Multimedia
Podcasts (41)
Webinars (4)
Section
Business (51053)
Career Advice (462)
Deals (9917)
Drug Delivery (45)
Drug Development (22140)
Employer Resources (51)
FDA (4248)
Job Trends (5090)
News (87058)
Policy (8208)
Tag
2024 BioForest Digital (1)
2024 BioForest Standard (1)
2024 BioMidwest Standard (1)
2024 Bio NC Digital (2)
2024 Biotech Bay Standard (7)
2024 Biotech Beach Digital (1)
2024 Biotech Beach Standard (2)
2024 Genetown Standard (3)
2024 Pharm Country Standard (3)
2025 Lone Star Bio Digital (1)
2026 BioCapital Standard (1)
2026 BioMidwest Elite (1)
2026 Biotech Bay Elite (1)
2026 Biotech Beach Elite (1)
2026 Genetown Elite (2)
2026 Pharm Country Elite (1)
Academia (930)
Academic (1)
Accelerated approval (1)
Adcomms (3)
Allergies (34)
Alliances (10454)
ALS (44)
Alzheimer's disease (614)
Antibody-drug conjugate (ADC) (21)
Approvals (4305)
Artificial intelligence (115)
Autoimmune disease (9)
Automation (3)
Bankruptcy (75)
Best Places to Work (4711)
BIOSECURE Act (9)
Biosimilars (31)
Biotechnology (28)
Bladder cancer (26)
Brain cancer (5)
Breast cancer (108)
Cancer (747)
Cardiovascular disease (71)
Career advice (397)
Career pathing (14)
CAR-T (40)
Cell therapy (120)
Cervical cancer (9)
Clinical research (18700)
Collaboration (298)
Compensation (67)
Complete response letters (4)
COVID-19 (755)
CRISPR (12)
C-suite (83)
Cystic fibrosis (30)
Data (1020)
Decentralized trials (1)
Denatured (14)
Depression (13)
Diabetes (106)
Diagnostics (2197)
Digital health (6)
Diversity (2)
Diversity, equity & inclusion (12)
Drug discovery (40)
Drug pricing (40)
Drug shortages (6)
Duchenne muscular dystrophy (41)
Earnings (27157)
Editorial (11)
Employer branding (4)
Employer resources (45)
Events (22617)
Executive appointments (281)
FDA (4792)
Featured Employer (14)
Friedreich's ataxia (1)
Frontotemporal dementia (5)
Funding (320)
Gene editing (28)
Generative AI (14)
Gene therapy (104)
GLP-1 (189)
Government (1468)
Grass and pollen (1)
Guidances (34)
Healthcare (6279)
Huntington's disease (3)
IgA nephropathy (6)
Immunology and inflammation (28)
Indications (13)
Infectious disease (812)
Inflammatory bowel disease (52)
Inflation Reduction Act (7)
Influenza (24)
Intellectual property (39)
Interviews (61)
IPO (5395)
IRA (20)
Job creations (683)
Job search strategy (321)
Kidney cancer (2)
Labor market (10)
Layoffs (126)
Leadership (11)
Legal (1357)
Liver cancer (20)
Lung cancer (101)
Lymphoma (56)
Machine learning (3)
Management (22)
Manufacturing (98)
MASH (32)
Medical device (4128)
Medtech (4130)
Mergers & acquisitions (4767)
Metabolic disorders (259)
Multiple sclerosis (35)
NASH (7)
Neurodegenerative disease (23)
Neuropsychiatric disorders (4)
Neuroscience (820)
NextGen: Class of 2025 (1744)
Non-profit (2243)
Northern California (935)
Now hiring (2)
Obesity (127)
Opinion (82)
Ovarian cancer (29)
Pain (28)
Pancreatic cancer (39)
Parkinson's disease (64)
Partnered (14)
Patents (65)
Patient recruitment (37)
Peanut (17)
People (12368)
Pharmaceutical (10)
Pharmacy benefit managers (4)
Phase I (4966)
Phase II (8101)
Phase III (7119)
Pipeline (546)
Policy (67)
Postmarket research (704)
Preclinical (1925)
Press Release (10)
Prostate cancer (37)
Psychedelics (8)
Radiopharmaceuticals (74)
Rare diseases (141)
Real estate (793)
Recruiting (19)
Regulatory (6138)
Reports (17)
Research institute (802)
Resumes & cover letters (83)
Rett syndrome (4)
RNA editing (1)
RSV (21)
Schizophrenia (22)
Series A (49)
Series B (35)
Service/supplier (2)
Sickle cell disease (23)
Southern California (797)
Special edition (2)
Spinal muscular atrophy (46)
Sponsored (17)
Startups (722)
State (1)
Stomach cancer (3)
Supply chain (21)
Tariffs (16)
The Weekly (26)
United States (8075)
Vaccines (201)
Venture capitalists (8)
Weight loss (58)
Women's health (12)
Worklife (7)
Date
Last 7 days (186)
Last 30 days (820)
Last 365 days (12533)
2025 (3503)
2024 (13376)
2023 (15417)
2022 (21154)
2021 (22515)
2020 (20197)
2019 (13142)
2018 (9536)
2017 (7294)
2016 (6559)
2015 (7122)
2014 (4743)
2013 (3541)
2012 (3745)
2011 (4038)
2010 (3336)
Location
Africa (179)
Alabama (28)
Alaska (4)
Arizona (48)
Arkansas (3)
Asia (9636)
Australia (1229)
California (2088)
Canada (708)
China (132)
Colorado (101)
Connecticut (91)
Delaware (53)
Europe (21425)
Florida (308)
Georgia (62)
Idaho (15)
Illinois (202)
India (11)
Indiana (114)
Iowa (1)
Japan (63)
Kansas (19)
Kentucky (5)
Louisiana (6)
Maine (36)
Maryland (291)
Massachusetts (1522)
Michigan (85)
Minnesota (127)
Missouri (39)
Montana (5)
Nebraska (4)
Nevada (23)
New Hampshire (43)
New Jersey (644)
New Mexico (3)
New York (773)
North Carolina (307)
North Dakota (3)
Northern California (935)
Ohio (74)
Oklahoma (6)
Oregon (12)
Pennsylvania (511)
Puerto Rico (6)
Rhode Island (6)
South America (282)
South Carolina (8)
Southern California (797)
Tennessee (50)
Texas (276)
Utah (60)
Virginia (43)
Washington D.C. (28)
Washington State (204)
West Virginia (1)
Wisconsin (17)
173,921 Results for "impact biomedicines".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Ampersand Biomedicines Raises Series B Financing and Highlights Pipeline Advancements
March 19, 2025
·
3 min read
Press Releases
Ampersand Biomedicines Appoints Elizabeth Mily to Board of Directors
February 11, 2025
·
2 min read
Press Releases
Sail Biomedicines Appoints Laura Sepp-Lorenzino, Ph.D., to Its Board of Directors
April 7, 2025
·
2 min read
Press Releases
Endeavor BioMedicines Appoints Internationally Renowned ILD Expert Lisa Lancaster, M.D., as Chief Medical Officer
April 2, 2025
·
2 min read
Press Releases
Positive Adherence Impact of IPUMP® Connected Assistant for Sublingual Liquid Allergen Immunotherapy Treatment
April 14, 2025
·
4 min read
Press Releases
Inventiva announces the publication in Biomedicine & Pharmacotherapy of the results from a preclinical study showing improvement of portal hypertension with lanifibranor treatment
February 27, 2025
·
13 min read
Press Releases
Vistagen Presents New Research on the Impact of Social Anxiety Disorder at The Anxiety and Depression Association 2025 Conference
April 17, 2025
·
7 min read
Press Releases
NCCN 2025 Annual Conference Illustrates the Critical Impact of Cancer Research on Improving Lives
April 3, 2025
·
7 min read
Vaccines
GSK Builds on Real-World Experiment to Study Shingrix’s Impact on Dementia
The British pharmaceutical giant is working with the U.K. Dementia Research Institute to exploit a “natural randomization” experiment to determine whether 65- and 66-year-olds who received GSK’s shingles vaccine Shingrix have reduced dementia risk.
March 25, 2025
·
1 min read
·
Dan Samorodnitsky
Press Releases
NIH awards Feinstein Institutes $2 million to study impact of heat, stroke on people with Alzheimer’s disease
April 16, 2025
·
3 min read
1 of 17,393
Next
